Peer Review History
| Original SubmissionOctober 8, 2020 |
|---|
|
PONE-D-20-31664 A prospective survey of Streptococcus pyogenes infections in French Brittany from 2009 to 2017: Comprehensive dynamic of new emergent emm genotypes. PLOS ONE Dear Dr. Kayal, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The manuscript has been assessed by two reviewers. Their comments are available below. The reviewers have raised a number of concerns about the the data, they recommend revisions to provide a fuller outline of the methodology and main results. Please carefully revise the manuscript to address all the points raised by the two reviewers. Please submit your revised manuscript by Jan 01 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Jose Melo-Cristino, M.D., Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Overall this is an interesting study describing the clinical and genotying features of GAS infections in French Brittany between 2009 and 2017. The authors highlight the emergence of new emm-types and their association with clusters that differ from the prevalent emm types. Comments Abstract Line 22 – think there needs to be an additional word here such as ‘complex epidemiology driven by the diversity’ Abstract line 26 – I don’t think this study has the power to decipher the underlying mechanism for the emergence of successful clones given that only emm typing was performed. Introduction Line 61 – delete the word species Methods Line 130 – I am not quite clear on what is meant by collected exhaustively. Are all isolates routinely saved regardless of infection site? Is there likely to be an over-representation of invasive or severe GAS isolates? How much non-invasive or carriage would be collected? Results Line 177 – is the number of cases that same as the number of isolates or were several isolates obtained from the same patient? Line 192 (and other places) – two open square brackets are used rather than an open and close. Line 195 – what is meant here? That non-invasive infections would not be recorded or isolates not saved? Or is this something to do with management – ie no clinical outcomes or information recorded. I think a bit of clarity here (or in the Methods) would be good to try and get an idea of what sort of isolates would be included – it is not clear what sort of number of non-invasive infections would be recorded/collected. Also relates to Line 218-220 – is this related to the types on non-invasive isolates obtained here and only serious ones potentially related to invasive disease would be collected? Lines 243-245 – this section is a bit confusing. Is it 51% of invasive cases? Then 49% would not and this can’t be ‘most’. In the sentence starting ‘Its proportion’ what does the ‘it’ refer to? Line 255 – delete the word ‘finally’ Line 262 – ‘showed’ rather than ‘show’ Line 281 – ‘in their occurrence’ rather than ‘of their occurrence’ Line 301 – ‘associated with’ rather than ‘associating one’ Lines 321-325 should be in the Discussion Line 332 – hypothesising Line 363 – I do not really understand this sentence. Do you mean that no emergent emm types belonged to A-C, which was the most common of the prevalent genotypes? Line 378 – an extra bracket here. Also change ‘agree closely’ to ‘similar to’ or ‘in agreement with’ Line 380 – suggest changing to ‘that belonged to emm-clusters that “Sporadic” but not “Prevalent” genotypes were members of’ to improve clarity. Line 388 – delete the ‘the’ after observed Line 398 – delete the ‘the’ before invasiveness Line 400- what is meant here? The number of risk factors increase with age? Line 402 – delete the ‘The’ before gender Line 413 – emm28 and ee77 have R28 but not 4 and 12. Discussion Line 416 – ‘it has been known’ rather than ‘admitted’ Line 424 – ‘were dominant’ rather than ‘behaved lie’ Line 433 – delete ‘A’ before recent Line 439 – not sure what is meant here? No prevalent emm types were recorded during this time or that no prevalent emm types were of clusters D and E? Line 400 – ‘Were’ rather than ‘Have’ and ‘patients with’ rather than ‘patients having’ Line 455 – ‘was’ rather than ‘has been recorded’ Line 457 – should it be ‘where it represents’ rather than ‘while it represents’? Line 458 – do you mean if emm75 will become a “Prevalent” emm type? Line 472 – ‘may’ rather than ‘probably’ Line 483 – ‘potentially’ rather than ‘presumably’ Tables – it is not standard practice to have legends for Tables. A brief title is included and then any parts that need clarification should be footnotes. I don’t think there should be a part A and B to table 2 – this should be Table 2 and Table 3. Throughout the Methods and some of the Results the term ‘Strain’ is used when it should be ‘Isolate’ Reviewer #2: Boukthir et al report on a prospective survey of Streptococcus pyogenes infections in French Brittany from 2009 to 2017. It is an excellent study with good data. I can fully recommend the publication and have only a few minor comments. A small restriction from my side: I cannot judge the statistics sufficiently well. minor remarks lines 192-195 (and S3 Fig) To me the arrangement of the brackets for the representation of the age intervals seems to take some getting used to. lines 194-195 The percentages of 65% and 63% do not correspond to those given in S3 Figure. Furthermore, table 1 does not differentiate the different age intervals at all. table 1 Portal of Entry, Overall: 499, 247, 164 and 31 sum up (only) to 941 (not 942)? lines 246-247 Where does the number of 588 cases come from? I cannot find it anywhere else in the manuscript. Furthermore: 588/889 = 0.661417322… (=> 66%, not 67% as indicated) line 262 shows (not shown) line 263 The distribution can be seen better in table S1 than in figure 2. line 300 7/13 = 0.538461538 => (=> 54%, not 53% as indicated) lines 329-331 Please rephrase. lines 334-335 figure 3 (Fig 3) => Please remove the duplication. lines 339-347 I am not sure if I understand the description correctly, especially the front part. Probably this is fine, but if necessary it could be made a bit clearer. lines 377-378 The order of the emm types mentioned is different from that shown in figure 2 and table S1. Is this intentional? line 442 transposons => please correct line 455 …a specific… factors… => please rephrase line 516 Ygout (?) figure 2 It would be nice if the percent sign could also be included at 0-53 and 54-76 (top left). figure 3 It would be nice if in the middle column with the sporadic infections in figure 3a some more emm types could be marked in the figure. S3 figure To me the arrangement of the brackets for the representation of the age intervals seems to take some getting used to (see also lines 192-195). The percentages of 65% and 63% given in lines 194-195 do not correspond to those given in S3 Figure. For the age group of [30-40[, there should be a ‘-‘ instead of a ‘;’. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-31664R1 A prospective survey of Streptococcus pyogenes infections in French Brittany from 2009 to 2017: Comprehensive dynamic of new emergent emm genotypes. PLOS ONE Dear Dr. Kayal, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. I have some minor issues for the authors’ consideration: References in abstract (line 37). Please delete. Lines 73-75, “In contrast, in Africa and the Pacific region, the distribution of emm types exhibits a higher diversity explained by the non-observed dominant emm types [13].” Use of English. Lines 79-80, “In tropical countries, the most circulating emm types of GAS are of emm pattern D (skin tropism) or E (both skin and pharyngeal tropism) (…)”. Use of English. Lines 169-170, “Once validated, the dataset basis was completely anonymized.” The authors probably mean that the database was completely anonymized. Lines 177-179, “Out of the 21 areas of French Brittany, and as expected, GAS isolates were predominantly recovered from patients living in Rennes and surrounding areas and then decreased gradually (S1 Fig)”. Ambiguous meaning. Lines 180-182, “During the surveillance period, and as previously described, we also observed seasonal variation of the rate of infections (invasive and non-invasive), culminating in autumn/winter (S2 Fig)[23].” Perhaps “peaking”? Lines 231-232, “(…) the final diagnosis was septic arthritis (n=14), isolated bacteraemia (12), central nervous system infections (2), primary peritonitis (2), and pericarditis (1).” Here and elsewhere if number of cases is meant then these should be indicated by n=. Lines 358-361, “Finally, emm types clustered as a single protein, and for which it has been proposed that their M protein could have different immunological, structural, and functional characteristics were grouped in the same raw and encompassed “Prevalent” (emm6) and “Sporadic” (emm5, emm29, and emm105) emm types (Fig 3).” Replace raw with row? Lines 368-369, “Deciphering the temporal dynamic of emm genotypes, we observed five “Emergent” emm types that belonged to emm-clusters that “Sporadic” but not “Prevalent” genotypes were members of.” Use of English. Lines 436-437, “(…)(skin or generalist rather throat specialist strains)(…)” missing “than”. Lines 456-457, “This genotype upsurges last decades and has been linked recently to the emergence(…)”. Use of English. I invite you to submit a revised version of the manuscript that addresses these points. Please submit your revised manuscript by Jan 14 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Jose Melo-Cristino, M.D., Ph.D. Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
A prospective survey of Streptococcus pyogenes infections in French Brittany from 2009 to 2017: Comprehensive dynamic of new emergent emm genotypes. PONE-D-20-31664R2 Dear Dr. Kayal, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Jose Melo-Cristino, M.D., Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-31664R2 A prospective survey of Streptococcus pyogenes infections in French Brittany from 2009 to 2017: Comprehensive dynamic of new emergent emm genotypes. Dear Dr. Kayal: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Jose Melo-Cristino Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .